Therapeutic potential of the lazaroids (21-aminosteroids);Das therapeutische Potential der Lazaroide (21-Aminosteroide)

Deutsche Medizinische Wochenschrift

Volumn 122, Issue 44, 1997, Pages 1363-1367

  Buttgereit, F ^a,b   Hiepe, F ^a,b   Burmester, G R ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; LAZAROID; METHYLPREDNISOLONE; TIRILAZAD;

ANTIOXIDANT ACTIVITY; CENTRAL NERVOUS SYSTEM; DRUG ACTIVITY; DRUG MECHANISM; DRUG STRUCTURE; HUMAN; NERVOUS SYSTEM INJURY; REVIEW;

EID: 0030724299     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1047772     Document Type: Review

References (45)

1. Asano, T., T. Matsui, Y. Takuwa: Lipid peroxidation, proteinkinase C, and cerebral vasospasm. Crit. Rev. Neurosurg. 1 (1991), 361.
2. Barnes, P. J., I. Adcock: Anti-inflammatory actions of steroids. Molecular mechanisms. Trends Pharmacol. Science 14 (1993), 436.
3. Blankenhorn, G., I. Fischer, J. Seuß: Möglichkeiten und Grenzen der Antioxidans-Therapie entzündlich rheumatischer Erkrankungen mit hochdosiertem Vitamin E. Akt. Rheumatol. 10 (1985), 125-129.
4. Boumpas, D. T., G. P. Chrousos, R. L. Wilder, T. R. Cupps, J. E. Balow: Glucocorticoid therapy for immune-mediated diseases. Basic and clinical correlates. Ann. intern. Med. 119 (1993), 1198-1205.
5. Boumpas, D. T.: A novel action of glucocorticoids. NF-κB inhibition. Brit. J. Rheumatol. 35 (1996), 709-710.
6. Bracken, M. B., J. M. Shepard, W. F. Collins et al.: A randomized, controlled, trial of methylprednisolone or naloxane in the treatment of acute spinal cord injury. New Engl. J. Med. 322 (1990), 1405-1411.
7. Bracken, M. B., J. M. Shepard, W. F. Collins et al.: Methylprednisolone or naloxone treatment after acute spinal cord injury. J. Neurosurg. 76 (1992), 23-31.
8. Bracken, M. B.: Methylprednisolone and Tirilazad in acute spinal cord injury. International Conference on recent advances in neurotraumatology. September 8-11, 1996, Riccione, Italy.
9. Bryan, C. L., R. A. Lawrence, E. D. Hall, S. G. Jenkinson: 21-Aminosteroids inhibit microsomal lipid peroxidation independent of iron. FASEB-J. 4 (1990), 630-638.
10. + ions into Concanavalin A-stimulated thymocytes. Biochem. J. (1997), in press.
11. Buttgereit, F., S. Dimmeler, E. Neugebauer, C. R. Burmester: Wirkungsmechanismen der hochdosierten Glucocorticoidtherapie. Dtsch. med. Wschr. 121 (1996), 248-252.
12. Buttgereit, F., I. Brink, B. Thiele, F. Hiepe, G. R. Burmester, E. Hall: Effects of Methylprednisolone and 21-aminosteroids on mitogen-induced IL-6 and TNF-α production in human peripheral blood mononuclear cells. J. Pharm. Exp. Then 275 (1995), 850-853.
13. Buttgereit, F., M. Müller, K. Wolbart, B. Thiele, F. Hiepe: The influence of methylprednisolone on energy metabolism of Ehrlich ascites tumour cells. Biosci. Rep. 14 (1994a), 283-290.
14. Buttgereit, F., A. Grant, M. Müller, M. D. Brand: The effects of methylprednisolone on oxidative phosphorylation in Con A-stimulated thymocytes. Europ J. Biochem. 223 (1994b), 513-519.
15. Buttgereit, F., M. D. Brand, M. Müller: Effects of Methylprednisolone on the energy metabolism of quiescent and Con A-stimulated thymocytes of the rat. Biosci. Rep. 13 (1993), 41-52.
16. Cosenza, C. A., D. V. Cramer, S. A. Cunneen, P. J. Tuso, H. K. Wang, L. Makowka: Protective effect of the Iazaroid U74006F in cold ischemia-reperfusion injury of the liver. Hepatology 19 (1994), 418.
17. Cronstein, B. N., S. C. Kimmel, R. I. Levin, F. Martiniuk, G. Weissmann: A mechanism for the antiinflammatory effects of corticosteroids. Proc. Natl. Acad. Sci. 89 (1992), 9991-9995.
18. Eversole, R. R., S. L. Smith, L. J. Beuving, E. D. Hall: Protective effect of the 21-aminosteroid lipid peroxidation inhibitor tirilazad mesylate on hepatic endothelium in experimental hemorrhagic shock. Circ. Shock 40 (1993), 125-131.
19. Fleishaker, J. C., G. R. Peters, K. S. Cathcart: Evaluation of the pharmacokinetics and tolerability of tirilazad mesylate, a 21-aminosteroid free radical scavenger. I. Single-dose administration. J. clin. Pharmacol. 33 (1993a), 175-181.
20. Fleishaker, J. C., G. R. Peters, K. S. Cathcart, R. C. Steenwyk: Evaluation of the pharmacokinetics and tolerability of tirilazad mesylate, a 21-aminosteroid free radical scavenger. II. Multiple-dose administration. J. clin. Pharmacol. 33 (1993b), 182-190.
21. Gametchu, B., C. S. Watson, S. Wu: Use of receptor antibodies to demonstrate membrane glucocorticoid receptor in cells from human leukemic patients. FASEB-J. 7 (1993), 1283-1292.
22. Goulding, N. J., P. M. Guyre: Glucocorticoids, lipocortins and the immune response. Curr. Opin. Immunol. 5 (1993), 108-113.
23. Haley, E. C., N. F. Kasell, W. M. Alves, B. K. Weir, C. A. Hansen: Phase II trial of tirilazad in aneurysmal subarachnoid hemorrhage. J. Neurosurg. 82 (1995), 786-790.
24. Hall, E. D., J. M. McCall, E. D. Means: Therapeutic potential of the lazaroids (21-amino steroids) in acute central nervous system trauma, ischemia and subarachnoid hemorrhage. Adv. Pharmacol. 28 (1994), 221-268.
25. Hall, E. D.: The neuroprotective pharmacology of methylprednisolone. J. Neurosurg. 76 (1992), 13-22.
26. Hall, E. D., J. M. Braughler: Free radicals in CNS injury. In Waxman, S. G. (Ed.): Molecular And Cellular Approaches To The Treatment Of Neurological Disease. (Raven Press: New York 1993), 81-105.
27. Hinzmann, J. S., R. L. McKenna, T. S. Pierson, F. Han, F. J. Kezdy, D. E. Epps: Interaction of antioxidants with depth-dependent fluorescence quenchers and energy transfer probes in lipid bilayers. Chem. Phys. Lipids 62 (1992), 123-138.
28. Janknecht, R., T. Hunter: A growing coactivator network. Nature 383 (1996), 22-23.
29. Kassell, N. F., E. C. Haley, C. Apperson-Hansen, W. M. Alves: Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage. J. Neurosurg. 84 (1996) 221-228.
30. Kaiser, H., H. K. Kley: Cortisontherapie: Corticoide in Klinik und Praxis. (Thieme: Stuttgart 1992).
31. Katz, S. M., S. Sun, R. S. Schechner, V. A. Tellis, E. R. Alt, S. M. Greenstein: Improved small intestinal preservation after lazaroid U74 389 G treatment and cold storage in University of Wisconsin solution. Transplantion 59 (1995), 694-698.
32. Liu, P., S. L. Vonderfecht, G. M. McGuire et al.: The 21-aminosteroid Tirilazad mesylate protects against endotoxin shock and acute liver failure in rats. J. Pharm. Exp. Ther. 271 (1994), 438-445.
33. Martens, M. E., P. L. Peterson, C. P. Lee: In vitro effects of glucocorticoid on mitochondrial energy metabolism. Biochim. Biophys. Acta 1058 (1991), 152-160.
34. Mathews, W. R., C. K. Marshcke, R. McKenna: Tirilazad mesylate protects endothelium from damage by reactive oxygen. J. molec. Cell Cardiol. 24, suppl. III (1992), 517.
35. McKenna, R., F. J. Kezdy, D. E. Epps: Kinetic analysis of the free radical-induced lipid peroxidation in human erythrocyte membranes. Anal. Biochem. 196 (1991), 443-450.
36. Moore, F. L., M. Orchinik: Membrane receptors for corticosterone. Horm. Behav. 28 (1994), 512-519.
37. Park, C. K., E. D. Hall: Dose-response analysis of the effect of 21-aminosteroid tirilazad mesylate (U-74006 F) upon neurological outcome and ischemic brain damage in permanent focal cerebral ischemia. Brain Res. 645 (1994), 157-163.
38. Palogianni, F., S. S. Ahuja, J. P. Balow, J. E. Balow. D. T. Boumpas: Novel mechanism for inhibition of human T cells by Glucocorticoids (GC). J. Immunol. 151 (1993), 4081-4089.
39. Richards, I. M., R. L. Griffin, S. F. Fidler, E. J. Jacobsen: Effect of the 21-aminosteroid, U 74 389 F, on hyperoxic lung injury in rats. Agents and Actions 39 (1993), 136-138.
40. Schmidt, K., W. Bayer, G. Blankenhorn: Vitamin E - aktueller wissenschaftlicher Erkenntnisstand. VitaMinSpur 5 (1990), 3-18.
41. Semrad, S. D., R. Dubielzig: Effect of repeated administration of tirilazad mesylate on healthy and endotoxemic calves. A pilot study. Can. J. Vet. Res. 58 (1994), 67-70.
42. Shenkar, R., E. Abraham: Effects of treatment with the 21-aminosteroid, U74 38 F, on pulmonary cytokine expression following hemorrhage and resuscitation. Crit. Care Med. 23 (1995), 132-139.
43. Traystman, R. J., J. R. Kirsch, R. C. Koehler: Oxygen radical mechanisms of brain injury following ischemia and reperfusion. J. appl. Physiol. 71 (1991), 1185-1195.
44. Zhang, H., H. Spapen, P. Manikis, P. Rogiers, G. Metz, W. A. Buurman, J. L. Vincent: Tirilazad mesylate inhibits effects of endotoxin in dogs. Amer. J. Physiol. 268 (1995), 1847-1855.
45. Zuccarello, M., J. T. Marsch, G. Schmitt, J. Woodward, D. K. Anderson: Effect of the 21-aminosteroid U74006 F on cerebral vasospasm following subarachnoid hemorrhage. J. Neurosurg. 71 (1989), 98-104.